OTC SKIN CLOSURE NOW AVAILABLE TOO! Visit www.DermaQuik.com

DermaClip, An Innovative Advance in Non-Invasive Wound Closure: A New Paradigm

Military Medicine Journal Volume 183 featuring DermaClip Peer Reviewed Article 'An Innovative Advance in Non-invasive Wound Closure: A New Paradigm' by Drs. Jeffrey S. Freed $amp; John Ko

Houston, TX – 4/04/2018. DermaClip® is pleased to announce the publishing of its first peer reviewed article in the United States. Dr. Jeffrey S. Freed and Dr. John Ko's article "An Innovative Advance in Non-invasive Wound Closure: A New Paradigm" was published in Military Medicine, the official international journal of the Association of Military Surgeons of the United States (AMSUS).

Abstract (as published by Military Medicine)

Injury is the leading health and readiness threat to the armed forces, with two million instances per year; therefore, innovating wound care solutions can help improve readiness. The DermaClip® Skin Closure Device is a new, non-invasive, painless, and easy-to-apply wound closure device that does not require either needles or painful anesthesia injections or create additional damage to the wounded area. The efficacy of the device was tested in a 120-patient trial, composed of 60 experimental cases and 60 control cases. The trial of the DermaClip® device demonstrated the device’s efficacy in meeting the needs of clinical applications. Additionally, the experimental group had no adverse events in the product safety test. The efficacy of the device coupled with the features of ease of use and limited requirements for application make this a wound closure device particularly applicable to the emergency and battlefield setting.

Read the full article.

"The DermaClip® team is excited about this article's publication and is appreciative of all the work put in by Dr. Freed, Dr. Ko, and the team at Military Medicine. DermaClip® will continue to work towards mitigating the health and readiness threat of injuries," said Charles M. Darling, IV, CEO of DermaClip® US LLC.

For more information about the DermaClip® device, visit the DermaClip website.

Disclosure: Dr. Freed is the Chief Medical Officer of DermaClip® US, LLC and Dr. Ko is on the DermaClip® Medical Advisory Board.

About Military Medicine

Military Medicine is the official international journal of AMSUS. Articles published in the journal are peer-reviewed scientific papers, case reports, and editorials. The journal also publishes letters to the editor. It is currently under the leadership of its Editor-in-Chief Stephen W. Rothwell Ph.D.

Referenced in Index Medicus and on the MEDLARS system, Military Medicine is a valuable educational and informational resource for all federal health professionals.

Military Medicine is AMSUS’ official peer-reviewed journal. The objective of the journal is to promote awareness of federal medicine by providing a forum for responsible discussion of common ideas and problems relevant to federal healthcare.

AMSUS membership includes a subscription to the journal available in print and online. For more information, visit Military Medicine.

About DermaClip®

The DermaClip® skin closure device is a unique, newly-developed non-invasive skin closure device made of hypoallergenic adhesive coupled with a polypropylene bridge that allows for the quick and easy approximation of skin edges at the time of final closure of a wound. It removes the necessity for local anesthesia, alleviates skin puncture by sutures and staples, and eliminates the possibility of skin reaction to glues, eliminating potential sources of pain and complications for the patient. The patented single-use, needle-less device is designed to evert skin edges, avoiding the possibility of unsightly wound inversion. The device accomplishes this with remarkable speed allowing for decreased preparation, time-to-closure and absence of staple or suture cross-hatching. This results in decreased overall costs while being designed to improve the cosmesis of wound healing.

We, at DermaClip®, believe that this high quality skin closure system should be available to everyone, allowing all involved in wound closure -- the patient, the medical professional and the institutions providing the service -- to benefit from the advantages of this product.

The US operations of DermaClip® are owned and operated by DermaClip® US, L.L.C., a Texas based company. For more information, visit the DermaClip website.